This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Drug Therapy, Other  • Psychiatry  • Depression  • Adverse Effects  • Alert me on articles by topic

Sarah Ringold, MD

JAMA. 2005;293:537-538.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The controversial black-box warning for antidepressants describing the possible link between use of these drugs and suicide in adolescents has sparked an active debate regarding the appropriate treatment of depression in younger patients. The warning, required in the labeling of at least 32 commonly prescribed antidepressants, not only focuses attention on concerns about these medications for pediatric patients but also highlights a widening gap between the needs of the approximately 2.7 million US children and adolescents with significant depression and the nation’s relatively small number of trained child psychiatrists.

(Photo credit: Stockbyte/PictureQuest)

However, a growing recognition of this unmet need is driving new efforts to address the problem. Primary care pediatricians, family medicine practitioners, and psychiatrists are collaborating to formulate and promote guidelines and other measures. State health departments and other government agencies are also working with physician groups on initiatives to facilitate access to care on . . . [Full Text of this Article]

PRESCRIPTIONS EBBING